Final Analysis of Early Access Protocol with AA in mCRPC Patients

ASCO 2014 - Final Analysis of a Large, Open-label Global Early Access Protocol with Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer Progressing After Chemotherapy

Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals

Click HERE to view the poster from this session